HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Garcia-Porrua Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

7/2006Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
5/2006Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.
1/2006Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
5/2002Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms and giant cell arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Garcia-Porrua Research Topics

Disease

8Giant Cell Arteritis (Horton Disease)
03/2007 - 07/2000
8Rheumatoid Arthritis
07/2006 - 01/2001
5Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2004 - 09/2000
3Sarcoidosis (Schaumann Disease)
03/2014 - 12/2001
3Purpura
09/2006 - 05/2001
3Atherosclerosis
07/2006 - 01/2006
2Vascular Skin Diseases
09/2006 - 11/2003
2Erythema Nodosum
03/2004 - 12/2001
2Disease Susceptibility (Diathesis)
01/2004 - 06/2001
2Anemia
01/2004 - 07/2001
2Vasculitis (Vasculitides)
07/2002 - 05/2001
1Systemic Vasculitis
03/2007
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2007
1Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
09/2006
1Insulin Resistance
01/2006
1Diabetes Mellitus
01/2006
1Polyarteritis Nodosa (Periarteritis Nodosa)
11/2003
1Spondylarthropathies
11/2003
1Necrosis
02/2002
1Mononeuropathies (Mononeuritis Multiplex)
02/2002
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2001
1Inflammation (Inflammations)
02/2001
1Disease Progression
09/2000
1Osteitis
09/2000
1Arthritis (Polyarthritis)
09/2000
1Neoplasms (Cancer)
09/2000

Drug/Important Bio-Agent (IBA)

7HLA-DRB1 Chains (HLA DRB1)IBA
03/2014 - 01/2001
5Infliximab (Remicade)FDA Link
07/2006 - 02/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2006 - 05/2002
2E-SelectinIBA
03/2004 - 07/2002
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2001 - 05/2001
2HLA-DRB1*04 antigenIBA
07/2001 - 07/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2000 - 09/2000
1HLA-B Antigens (HLA-B)IBA
03/2007
1micaIBA
03/2007
1Macrophage Migration-Inhibitory FactorsIBA
09/2006
1Adalimumab (Humira)FDA Link
05/2006
1Glucose (Dextrose)FDA LinkGeneric
01/2006
1Insulin (Novolin)FDA Link
01/2006
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2004
1Interferon-gamma (Interferon, gamma)IBA
01/2004
1Hemoglobins (Hemoglobin)IBA
01/2004
1CytokinesIBA
01/2004
1Interleukin-1 (Interleukin 1)IBA
05/2002
1Corticotropin-Releasing HormoneIBA
03/2002
1Interleukin-6 (Interleukin 6)IBA
03/2002
1Monoclonal AntibodiesIBA
02/2002
1Codon (Codons)IBA
05/2001
1Biomarkers (Surrogate Marker)IBA
02/2001
1Aspartic Acid (Aspartate)FDA Link
02/2001
1Amino AcidsFDA Link
02/2001
1Prednisone (Sone)FDA LinkGeneric
09/2000
1antineoplaston A10 (A 10)IBA
09/2000

Therapy/Procedure

3Therapeutics
07/2006 - 01/2006